Product Name | MF | CAS | Details |
---|
5-Methyl-[1,2,4]triazolo[1,5-a]pyridine | C7H7N3 | 4931-27-5 | Details |
Vortioxetine Impurity 36 | C18H22N2S | 47159-85-3 | Details |
Vilanterol Impurity 19 | C23H31Cl2NO5 | 503070-62-0 | Details |
4-Iodo-isothiazole | C3H2INS | 49602-28-0 | Details |
Almotriptan Impurity 6 | C44H48N4O4S2 | 438226-83-6 | Details |
Oxytetracycline Impurity 7 | C22H22N2O8 | 4660-26-8 | Details |
6-Benzothiazolemethanamine | C8H8N2S | 499770-92-2 | Details |
Lipoic Acid Impurity 24 | C10H16O3 | 50628-92-7 | Details |
Raloxifene Impurity 23 | C14H10O3S | 414861-41-9 | Details |
Tirofiban Impurity 10 | C9H18ClN | 464175-13-1 | Details |
Ambroxol Impurity 37 | C7H5Br2NO | 42460-62-8 | Details |
Benzoic acid, 3-[[[(2R,4R)-4-mercapto-2-pyrrolidinyl]carbonyl]amino]-, hydrochloride (1:1) | C12H15ClN2O3S | 503607-49-6 | Details |
α-[2-(Acetylamino)ethyl]-α-phenylbenzeneacetamide | C18H20N2O2 | 503599-41-5 | Details |
Arformoterol Tartrate Impurity 3 | C9H11NO3 | 477552-94-6 | Details |
Econazole Impurity 14 | C8H5Cl3 | 45892-47-5 | Details |
6-(Hydroxymethyl)-2H-benzo[b][1,4]thiazin-3(4H)-one | C9H9NO2S | 443955-31-5 | Details |
Sildenafil Impurity 81 | C8H14N4O | 503064-95-7 | Details |
4-(5-((1H-1,2,4-Triazol-1-yl)methyl)-1H-1,2,4-triazol-3-yl)pyridine | C10H9N7 | 477852-54-3 | Details |
5-(Dimethylamino)-2-nitrobenzaldehyde | C9H10N2O3 | 548798-23-8 | Details |
Azetidine-3-carbonitrile | C4H6N2 | 732976-86-2 | Details |
1-Naphthalenamine, 4-(4-chlorophenyl)-1,2,3,4-tetrahydro-N-methyl-, hydrochloride, (1R-cis)- | C17H19Cl2N | 79617-90-6 | Details |
3-(3-Methoxyisoxazol-5-yl)propanoic acid | C7H9NO4 | 52898-06-3 | Details |
Methanediol, 1-[2-(acetyloxy)-2,5-dihydro-5-nitro-2-furanyl]-, 1,1-diacetate | C11H13NO9 | 5904-70-1 | Details |
Ozagrel Impurity 34 | C13H12N2O2.ClH | 78712-45-5 | Details |
Tetrahydro-2,5-furandimethanamine | C6H14N2O | 66918-21-6 | Details |
Megestrol Acetate Ep Impurity C | C24H32O4 | 74910-22-8 | Details |
3-Bromo-2H-furan-5-one | C4H3BrO2 | 56634-50-5 | Details |
2,7-Dihexyl[1]benzothieno[3,2-b][1]benzothiophene | C26H32S2 | 583050-69-5 | Details |
Mirabegron Impurity 76 | C8H7NO2 | 7505-92-2 | Details |
Phenylephrine Ep Impurity C | C9H11NO2 | 52093-42-2 | Details |
8-Methyl-3-(trifluoromethyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine | C7H9F3N4 | 611240-66-5 | Details |
N-(3,4-dimethoxyphenethyl)acetamide | C12H17NO3 | 6275-29-2 | Details |
2-(Difluoromethyl)-1-fluoro-4-nitrobenzene | C7H4F3NO2 | 63878-71-7 | Details |
2-(Cyclohexylamino)-1-phenylethan-1-ol | C14H21NO | 6589-48-6 | Details |
Sildenafil Impurity 152 | C8H12N4O3 | 792969-85-8 | Details |
Ampicillin Impurity 19 | C16H16N2O5S | 55675-51-9 | Details |
4,6-Dimethoxy-1,3-benzothiazol-2-amine | C9H10N2O2S | 65948-18-7 | Details |
N-Carbamoyl-2-(2,6-Dichlorophenyl)Acetamide | C9H8Cl2N2O2 | 78622-22-7 | Details |
methyl 3-(phenylamino)benzoate | C14H13NO2 | 55622-43-0 | Details |
N-Carbamoyl-D-P-Hydroxyphenylglycine | C9H10N2O4 | 68780-35-8 | Details |
Benzydamine Impurity 3 | C19H23N3O | 52413-42-0 | Details |
4-amino-1-((2R,4R,5R)-4-((tert-butyldimethylsilyl)oxy)-5-(((tert-butyldimethylsilyl)oxy)methyl)-3,3-difluorotetrahydrofuran-2-yl)pyrimidin-2(1H)-one | C21H39F2N3O4Si2 | 688009-09-8 | Details |
7-Oxa-2-azaspiro[4.5]Decane | C8H15NO | 72088-42-7 | Details |
Vigabatrin Impurity 15 | C7H9NO3 | 71107-20-5 | Details |
Paliperidone Impurity 66 | C12H14FNO2 | 767582-67-2 | Details |
Anagrelide Impurity 16 | C6HCl3N2O4 | 6379-46-0 | Details |
Ethynyldiphenylphosphane | C14H11P | 6104-47-8 | Details |
Loxoprofen Impurity 38 | C14H18O | 639857-67-3 | Details |
Naproxen Impurity 53 | C15H18O | 701270-26-0 | Details |
Estradiol Benzoate Ep Impurity E | C25H28O3 | 6045-53-0 | Details |
(S)-(+)-Nirvanol | C11H12N2O2 | 65567-34-2 | Details |
Isosorbide Impurity 16 | C8H12O5 | 65940-93-4 | Details |
(2S,3S,4S,5R,6R)-3,4,5,6-tetrahydroxytetrahydro-2H-pyran-2-carboxylic acid compound with 2-propylpentanoic acid (1:1) | C14H24O8 | 60113-83-9 | Details |
1,4-Dihydro-1,4-ethanonaphthalene | C12H12 | 7322-46-5 | Details |
3-Cyclopropylprop-2-ynoic acid | C6H6O2 | 7358-93-2 | Details |
4-(4-Chlorophenyl)butan-1-amine | C10H14ClN | 63998-62-9 | Details |
3-Bromo-2-(2,2,2-trifluoroethoxy)pyridine | C7H5BrF3NO | 760207-89-4 | Details |
5-(Tert-butyl)-1H-imidazol-2-amine | C7H13N3 | 82560-19-8 | Details |
Tranexamic Acid Impurity 14 | C8H5Cl3O2 | 5264-40-4 | Details |
Ranitidine Impurity 7 | C8H12ClNO | 82301-45-9 | Details |
(R)-4-bromo-1,2-epoxybutane | C4H7BrO | 79413-93-7 | Details |
4-Methoxycyclohexa-3,5-Diene-1,2-Dione | C7H6O3 | 69818-23-1 | Details |
Phloroglucinol Impurity 28 | C18H14O9 | 62218-04-6 | Details |
Faropenem Impurity 13 | C12H17NO6S | 754152-74-4 | Details |
Etoricoxib Impurity J | C19H17ClN2O2S | 646459-45-2 | Details |
(2R,3S,4R,5R)-2,3,4-Tris[(trimethylsilyl)oxy]-5-[[(trimethylsilyl)oxy]methyl]cyclohexanone | C19H44O5Si4 | 639852-30-5 | Details |
Diethyl 2-(hydroxyimino)malonate | C7H11NO5 | 6829-41-0 | Details |
7-Bromo-2,3,4,9-tetrahydro-1H-carbazole | C12H12BrN | 78863-99-7 | Details |
1H-Imidazole-1-butanenitrile, 2-methyl-α,α-diphenyl-, phosphate (1:1) | C20H22N3O4P | 562091-56-9 | Details |
4,5-Dibromo-1-methyl-1h-pyrrole-2-carboxylic acid | C6H5Br2NO2 | 66067-06-9 | Details |
5,7-Dichloro-[1,2,4]triazolo[1,5-a]pyrimidine | C5H2Cl2N4 | 78706-26-0 | Details |
Minodronic Acid Impurity 33 | C4H9O5P | 65359-99-1 | Details |
4-((1s,4r)-4-Heptylcyclohexyl)benzoic acid | C20H30O2 | 65355-31-9 | Details |
Etoricoxib Impurity 47 | C26H22ClNO4S2 | 646459-51-0 | Details |
Methyl 6-methoxy-4-oxo-1,4-dihydroquinoline-2-carboxylate | C12H11NO4 | 82633-20-3 | Details |
3-(3-Chloroisoxazol-5-yl)propanoic acid | C6H6ClNO3 | 80403-82-3 | Details |
8-Methoxy-1,2-Dihydronaphthalene | C11H12O | 60573-59-3 | Details |
1-Methyl-5-(trifluoromethyl)-1H-indazol-3-amine | C9H8F3N3 | 5685-69-8 | Details |
1h,4h,5h,6h-Cyclopenta[c]pyrazol-4-one | C6H6N2O | 596844-18-7 | Details |
5-Ethyl-1H-pyrrole-2-carboxylic acid | C7H9NO2 | 630128-54-0 | Details |
Hydantoin Impurity 3 | C16H14N2O2 | 4224-00-4 | Details |
Epinastine Impurity 35 | C23H22N2O2 | 439288-43-4 | Details |
5-Chloro-6-methoxy-1,3-benzothiazol-2-amine | C8H7ClN2OS | 74821-70-8 | Details |
Roxadustat Impurity 19 | C20H18N2O5 | 808120-20-9 | Details |
1-Propanone, 2-methyl-1-phenyl-3-(1-piperidinyl)-, hydrochloride (1:1) | C15H21NO | 6281-80-7 | Details |
Piperazine, 1-[(3-methylphenyl)methyl]-, hydrochloride (1:2) | C12H20Cl2N2 | 5321-61-9 | Details |
Levosimendan Impurity 15 | C13H17N3O | 52240-42-3 | Details |
Latamoxef Impurity 32 | C30H27ClN2O6 | 68314-38-5 | Details |
Tobramycin Impurity 12 | C19H38N6O10 | 64332-33-8 | Details |
Rosuvastatin Impurity 101 | C26H34FN3O6S | 615556-96-2 | Details |
Ethyl 4-[2-hydroxy-3-[(1-methylethyl)amino]propoxy]benzenepropanoate | C17H27NO4 | 81147-95-7 | Details |
(S)-4-Methyldihydrofuran-2(3H)-one | C5H8O2 | 64190-48-3 | Details |
Tirofiban Impurity 58 | C10H15N | 6304-31-0 | Details |
Framycetin Sulfate Ep Impurity F; Neomycin Sulfate Ep Impurity F | C23H45N5O14 | 51795-47-2 | Details |
2,3-Dimethyl-1H-pyrrole | C6H9N | 600-28-2 | Details |
Blonanserin Impurity 31 | C9H7FN2 | 71682-85-4 | Details |
2-Naphthalenecarboxylic acid, 4-methoxy- | C12H10O3 | 5773-93-3 | Details |
(2S,3S,3aR,9aS)-2,3,3a,9a-Tetrahydro-3-hydroxy-2-(hydroxymethyl)-7-methyl-6H-furo[2',3':4,5]oxazolo[3,2-a]pyrimidin-6-one | C10H12N2O5 | 433733-92-7 | Details |
(R)-2-Methylazetidine hydrochloride | C4H10ClN | 791614-71-6 | Details |
Rizatriptan Impurity 13 | C9H10BrN5O2 | 6085-99-0 | Details |
Product Total: Product Page: | ||||
274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 |